269 related articles for article (PubMed ID: 21911107)
1. Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium.
Grover S; Kumar V; Chakrabarti S
J Psychosom Res; 2011 Oct; 71(4):277-81. PubMed ID: 21911107
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium.
Yoon HJ; Park KM; Choi WJ; Choi SH; Park JY; Kim JJ; Seok JH
BMC Psychiatry; 2013 Sep; 13():240. PubMed ID: 24074357
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotics for delirium.
Lonergan E; Britton AM; Luxenberg J; Wyller T
Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
[TBL] [Abstract][Full Text] [Related]
4. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
Boettger S; Jenewein J; Breitbart W
Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793
[TBL] [Abstract][Full Text] [Related]
5. Risperidone versus olanzapine for the treatment of delirium.
Kim SW; Yoo JA; Lee SY; Kim SY; Bae KY; Yang SJ; Kim JM; Shin IS; Yoon JS
Hum Psychopharmacol; 2010; 25(4):298-302. PubMed ID: 20521319
[TBL] [Abstract][Full Text] [Related]
6. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
7. A double-blind trial of risperidone and haloperidol for the treatment of delirium.
Han CS; Kim YK
Psychosomatics; 2004; 45(4):297-301. PubMed ID: 15232043
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine Versus Haloperidol for Treatment of Delirium in Patients with Advanced Cancer: A Phase III Randomized Clinical Trial.
van der Vorst MJDL; Neefjes ECW; Boddaert MSA; Verdegaal BATT; Beeker A; Teunissen SCC; Beekman ATF; Wilschut JA; Berkhof J; Zuurmond WWA; Verheul HMW
Oncologist; 2020 Mar; 25(3):e570-e577. PubMed ID: 32162816
[TBL] [Abstract][Full Text] [Related]
10. One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia.
Keefe RS; Young CA; Rock SL; Purdon SE; Gold JM; Breier A;
Schizophr Res; 2006 Jan; 81(1):1-15. PubMed ID: 16202565
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
Alptekin K; Hafez J; Brook S; Akkaya C; Tzebelikos E; Ucok A; El Tallawy H; Danaci AE; Lowe W; Karayal ON
Int Clin Psychopharmacol; 2009 Sep; 24(5):229-38. PubMed ID: 19531959
[TBL] [Abstract][Full Text] [Related]
12. A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.
Crespo-Facorro B; Pérez-Iglesias R; Ramirez-Bonilla M; Martínez-García O; Llorca J; Luis Vázquez-Barquero J
J Clin Psychiatry; 2006 Oct; 67(10):1511-21. PubMed ID: 17107241
[TBL] [Abstract][Full Text] [Related]
13. Risperidone and olanzapine versus another first generation antipsychotic in patients with schizophrenia inadequately responsive to first generation antipsychotics.
Chen JJ; Chan HY; Chen CH; Gau SS; Hwu HG
Pharmacopsychiatry; 2012 Mar; 45(2):64-71. PubMed ID: 22086749
[TBL] [Abstract][Full Text] [Related]
14. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics for the treatment of delirious elders.
Ozbolt LB; Paniagua MA; Kaiser RM
J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
[TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of quetiapine and haloperidol in delirium: A single blind randomized controlled study.
Grover S; Mahajan S; Chakrabarti S; Avasthi A
World J Psychiatry; 2016 Sep; 6(3):365-71. PubMed ID: 27679777
[TBL] [Abstract][Full Text] [Related]
17. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL
J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial.
Agar MR; Lawlor PG; Quinn S; Draper B; Caplan GA; Rowett D; Sanderson C; Hardy J; Le B; Eckermann S; McCaffrey N; Devilee L; Fazekas B; Hill M; Currow DC
JAMA Intern Med; 2017 Jan; 177(1):34-42. PubMed ID: 27918778
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison.
Crespo-Facorro B; Pérez-Iglesias R; Mata I; Ramirez-Bonilla M; Martínez-Garcia O; Pardo-Garcia G; Caseiro O; Pelayo-Terán JM; Vázquez-Barquero JL
J Psychopharmacol; 2011 Jun; 25(6):744-54. PubMed ID: 21292922
[TBL] [Abstract][Full Text] [Related]
20. Drug therapy for delirium in terminally ill adults.
Finucane AM; Jones L; Leurent B; Sampson EL; Stone P; Tookman A; Candy B
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004770. PubMed ID: 31960954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
